The Scientific and Medical Team at Vyro Bio focuses on advancing the development of oncolytic viruses for targeting CNS tumors. This team conducts cutting-edge research, oversees laboratory operations, and provides expert medical insights, ensuring that the company's innovative treatments are both scientifically rigorous and clinically relevant. Their collaborative efforts aim to translate pioneering research into effective therapies for patients battling brain cancers.
View all